References

Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service

10.1002/ajmg.a.33139 · 2010 · External reference

Neurofibromatosis type 1

10.1038/nrdp.2017.4 · 2017 · External reference

Distinctive cancer associations in patients with neurofibromatosis type 1

10.1200/jco.2015.65.3576 · 2016 · External reference

Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study

10.1038/bjc.2012.535 · 2013 · External reference

Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1

10.1093/neuonc/noad033 · 2023 · External reference

Non-optic glioma in adults and children with neurofibromatosis 1

10.1186/s13023-017-0588-2 · 2017 · External reference

The molecular landscape of glioma in patients with Neurofibromatosis 1

10.1038/s41591-018-0263-8 · 2019 · External reference

Establishment and characterization of a novel malignant astrocytoma cell line derived from a tumor removed in a patient with neurofibromatosis type 1

10.3171/jns.2001.94.2.0301 · 2001 · External reference

Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects

10.1073/pnas.0401236101 · 2004 · External reference

Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects

10.1038/79075 · 2000 · External reference

Mouse models of tumor development in neurofibromatosis type 1

10.1126/science.286.5447.2172 · 1999 · External reference

Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies

10.1007/s10048-006-0078-5 · 2007 · External reference

PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies

10.1038/nature13561 · 2014 · External reference

Mouse tumor model for neurofibromatosis type 1

10.1126/science.286.5447.2176 · 1999 · External reference

Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1

10.1007/s00401-022-02478-5 · 2022 · External reference

Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas

10.1371/journal.pone.0277305 · 2023 · External reference

Dictionary learning for integrative, multimodal and scalable single-cell analysis

10.1038/s41587-023-01767-y · 2024 · External reference

DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors

10.1016/j.cels.2019.03.003 · 2019 · External reference

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

10.1038/nature20123 · 2016 · External reference

The multilayered transcriptional architecture of glioblastoma ecosystems

10.1038/s41588-025-02167-5 · 2025 · External reference

An integrative model of cellular states, plasticity, and genetics for glioblastoma

10.1016/j.cell.2019.06.024 · 2019 · External reference

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

10.1186/s13059-014-0550-8 · 2014 · External reference

Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasion

10.1016/j.cell.2021.03.023 · 2021 · External reference

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

10.1016/j.ccr.2009.12.020 · 2010 · External reference

Premalignant oligodendrocyte precursor cells stall in a heterogeneous state of replication stress prior to gliomagenesis

10.1158/0008-5472.can-20-1037 · 2021 · External reference

Mosaic analysis with double markers reveals tumor cell of origin in glioma

10.1016/j.cell.2011.06.014 · 2011 · External reference

Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process

10.1073/pnas.1414389111 · 2014 · External reference

Neurofibromas in NF1: Schwann cell origin and role of tumor environment

10.1126/science.1068452 · 2002 · External reference

Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow

10.1016/j.cell.2008.08.041 · 2008 · External reference

NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation

10.1038/s41467-018-07452-y · 2018 · External reference

Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity

2003 · External reference